Neta Zach

Company: Takeda Pharmaceutical Co. Ltd.

Job title: Head of Neuroscience Experimental Medicine

Seminars:

Assessing Neurofilament Light Changes in Presymptomatic Sporadic ALS 8:00 am

Understanding NfL changes prior to ALS diagnosis is critical to understanding disease pathology and planning for better diagnosis and clinical trial Large population datasets are critical to drive insights in presymptomatic individuals Using the UK biobank we characterized changes in NfL up to 10 years prior to ALS diagnosisRead more

day: Conference Day One Morning